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This study evaluates the performance of the antigen-
based anterior nasal screening programme imple-
mented in all Austrian schools to detect SARS-CoV-2 
infections. We combined nationwide antigen-based 
screening data obtained in March 2021 from 5,370 
schools (Grade 1–8) with an RT-qPCR-based prospec-
tive cohort study comprising a representative sample 
of 244 schools. Considering a range of assumptions, 
only a subset of infected individuals are detected with 
the programme (low to moderate sensitivity) and non-
infected individuals mainly tested negative (very high 
specificity).
Early recognition and isolation of infected individu-
als are crucial in containing the coronavirus disease 
(COVID-19) pandemic. Rapid antigen tests deliver 
timely results, can be performed without labora-
tory resources, and are widely used in screening 
programmes for severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) [1-3]. As transmission and 
outbreaks occur in educational settings [4], a nation-
wide screening programme was introduced at Austrian 
schools in January 2021 that implemented regular anti-
gen-based anterior nasal self-tests for pupils, teachers 
and administrative staff [5].
The present study aimed to evaluate the performance 
of the antigen-based screening programme for detect-
ing SARS-CoV-2 infections in Austrian schools. The 
design of the study is outlined in Figure 1. To provide 
context, the mean 7-day community incidence dur-
ing the study period was 198 per 100,000 individuals 
across all ages.
Nationwide rapid antigen test-based 
screening programme
The first component used aggregate data from the 
nationwide rapid antigen test-based screening pro-
gramme (Figure 1) provided by the Federal Ministry 
of Education, Science and Research. Data were col-
lected in Weeks 9–11 at primary schools (Grades 
1–4) and lower secondary schools (Grades 5–8) and 
involved 680,620 pupils and 104,087 teachers and 
administrative staff from 5,370 schools. Participants 
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were typically asymptomatic or pauci-symptomatic 
since pupils and teachers with symptoms were strictly 
advised to stay at home. Participation in the screen-
ing programme was free of charge, obligatory for 
in-person teaching, and required written informed 
consent. Participants conducted self-testing under the 
supervision of a teacher, twice per week in primary 
schools (Mondays, Wednesdays) and once per week in 
lower secondary schools (Mondays or Wednesdays as 
classes were split in two fixed cohorts and taught in 
school in a staggered manner). Mean participation rate 
over Weeks 9–11 was 98.5% (range: 96.4–98.8).
The screening programme used two rapid antigen 
tests licenced for anterior nasal self-testing (Lepu 
Medical SARS-CoV-2 Antigen Rapid Test, Lepu Medical 
Technology, Beijing, China [6]; and Flowflex SARS-
CoV-2 Antigen Rapid Test, ACON Biotech, Hangzhou, 
China [7]). The mean percentage tested positive each 
week is provided in the Table. Positively tested individ-
uals were sent home immediately and referred to the 
local health authorities as suspected cases for further 
testing.
Austrian School-SARS-CoV-2 study
The second component of this study used data from 
the Austrian School-SARS-CoV-2 study (Figure 1), a 
prospective cohort study involving pupils and teach-
ers from a representative sample of Austrian schools 
(Grade 1–8). Every 3–5 weeks during periods of the 
school year 2020/21 not affected by school closures, 
participants were tested for SARS-CoV-2 infection 
using gargling, pooling and in-house RT-qPCR analys-
ing multiple target genes (i.e. ORF1b, ORF10 and N, the 
latter being detected by two different assays N1 and 
N2). For all positive samples, at least two viral genes 
were detected. In addition, an RT-qPCR test for human 
RNA was included in all assays. The RT-qPCR controls 
included RNA extracts (i) from a previously tested posi-
tive sample with a target Cq value of 25 or synthetic 
SARS-CoV-2 RNA control (1 × 104 molecules per reac-
tion; Twist Biosciences, San Francisco, United States), 
(ii) from a previously tested negative sample and (iii) 
a no-template control. Further details on study design 
and methodology have been published previously [8].
Our analysis focused on Round 3 of the Austrian School-
SARS-CoV-2 study, which was conducted between 1 
and 18 March 2021 (Weeks 9–11) and included 6,423 
pupils and 1,100 teachers (from 244 schools) who had 
Figure 1
Study design for evaluating the performance of the rapid 
antigen test-based SARS-CoV-2 screening programme in 
schools, Austria, March 2021
a Included administrative staff.
Screening programme
Antigen-based self-test
Schools in Austria, grade 1-8





















Participants (n) % positivea Participants (n) % positiveb 95% CI
Pupils in primary schools 360,948 0.106 4,161 0.26 0.13–0.52
Pupils in lower secondary schools 319,672 0.063 2,262 0.13 0.04–0.41
Teachers at primary/lower secondary schools 104,087c 0.292 1,100 0.18 0.05–0.73
CI: confidence interval.
a For the antigen-based screening programme, the percentage tested positive was the mean percentage of participants tested positive each 
week weighted to the number of participating individuals. The percentages positive are provided without 95% CI because all pupils and 
educational staff were involved in the programme, rather than drawing a representative sample. The percentages of participants tested 
positive in Weeks 9, 10 and 11 were 0.088, 0.090 and 0.140 among pupils in primary schools, 0.055, 0.053 and 0.079 among pupils in lower 
secondary schools and 0.309, 0.313 and 0.254 among teachers and administrative staff in primary/lower secondary schools.
b 95% CI of prevalence estimates in the Austrian School-SARS-CoV-2 study were calculated from robust standard errors estimated based on 
clustered Sandwich estimators.
c Included administrative staff.
All participants in the School-SARS-CoV-2 study had before the study tested negative in the antigen-based screening programme.
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previously tested negative in the rapid antigen test-
based screening programme. Key findings on the prev-
alence of RT-qPCR-detected SARS-CoV-2 infection are 
shown in the Table. Overall prevalence did not differ 
significantly by time since the last antigen-based self-
test: Prevalence was 0.27% (8/2,985) in children and 
teachers with a negative self-test on the same day vs 
0.18% (8/4,538) for people with earlier rapid antigen 
testing (85% tested on the preceding day), correspond-
ing to an odds ratio of 1.51 (95% confidence interval: 
0.53–4.37; p = 0.435). There was no significant differ-
ence in Cq values among positively tested individu-
als in Round 3 compared with earlier rounds when no 
antigen-based screening programme had been in place 
(Figure 2). Of note, eight of 14 pupils and both teachers 
who tested positive by RT-qPCR had Cq values > 30 for 
all tested targets.
Estimated sensitivity and specificity of 
the Austrian antigen-based screening 
programme
We modelled sensitivity and specificity of the anti-
gen-based screening programme at Austrian schools 
by (i) combining findings from the two data sources, 
(ii) assuming a range of positive predictive values for 
the rapid antigen test (20–100%) and (iii) using point 
estimates and 95% confidence interval limits in the 
Austrian School-SARS-CoV-2 study as estimates of 
the negative predictive value (Figure 3). For instance, 
assuming a positive predictive value of 20%, sensitiv-
ity is expected in the range of 3.9–13.6% among pupils 
in primary schools, 3.0–22.6% among pupils in lower 
secondary schools and 7.4–56.5% among teachers. 
Corresponding sensitivity ranges are 10.9–32.0%, 8.4–
46.7% and 19.4–79.6% assuming a positive predictive 
value of 60%, and 17.0–44.0%, 13.3–59.4% and 28.7–
86.6% assuming a perfect positive predictive value of 
100%. The model indicated high specificity values at 
20%, 60% and 100% assumed positive predictive val-
ues of 99.92%, 99.6% and 100% for pupils in primary 
schools, 99.95%, 99.7% and 100% for pupils in lower 
secondary schools and 99.77%, 99.88% and 100% for 
teachers at primary/secondary schools.
Ethical statement
Ethical approval was not required for the data from 
the nationwide rapid antigen test-based screening 
programme because we used aggregate data only. 
The Austrian School-SARS-CoV-2 study received eth-
ics approvals by the ethics committees of the Medical 
University of Graz (no. 32–672 ex 19/20), Medical 
University of Innsbruck (no. 1319/2020), the Johannes 
Figure 2
Cq values of unpooled RT-qPCR of positively tested participants in Round 3 compared with Rounds 1 and 2, School-SARS-
CoV-2 study, Austria, March 2021 (n = 92 in Rounds 1 and 2, n = 16 in Round 3)
a Lowest value among the different Cq values of the RT-qPCR target genes.
Grey circles: Cq values of the individual RT-qPCR positive cases; black dots and vertical lines: their arithmetic means and 95% confidence 
intervals. N, ORF1b, and ORF10 are RT-qPCR target genes; N1 and N2 represent two different RT-qPCR assays for detection of the N-gene. 
A two-sample t-test was used to test for difference in Cq values between positively tested participants at Round 1 and 2 compared with 
positively tested participants at Round 3. Round 1 took place from 28 September to 22 October 2020 (40 RT-qPCR positive cases), Round 2 
















































Kepler University of Linz (no. 1222/2020), and the 
University of Vienna (no. 00591/2020). Participants or 
their legal representative provided written informed 
consent.
Discussion
The present study scrutinised the antigen-based 
screening programme introduced at Austrian schools 
in early 2021 to detect SARS-CoV-2 cases. While self-
collected anterior nasal swabs can be easily per-
formed, were well accepted by the children in our study 
and help increase testing capacities, knowledge about 
their performance in real-world settings are required to 
guide further decision-making.
While several studies exist on sensitivity and speci-
ficity of rapid antigen tests in adults [2], a recent 
Cochrane review identified a lack of large-scale data 
on the performance of serial antigen-based screening 
strategies in asymptomatic school-aged children [3]. 
Across various modelled scenarios, we observed lower 
sensitivity but similar specificity in children compared 
with prior studies in adults [3]. Collection of speci-
mens is not performed by trained medical staff but by 
pupils in Grades 1–8 and their teachers, which might 
substantially impact the detection rate. Furthermore, 
sensitivity of antigen-based tests is highest in symp-
tomatic patients, in whom viral loads are higher [9,10]. 
Less is known about viral loads in the anterior nasal 
region compared with the throat in asymptomatic peo-
ple and whether age-specific differences exist, but 
some data indicate that virus presence in the anterior 
nose can be delayed in asymptomatic people, leading 
to a lower detection rate in the early phase of infection 
[11,12]. Consequently, an a priori reduced sensitivity 
can be assumed in our cohort of asymptomatic indi-
viduals. Indeed, many individuals who falsely tested 
negative in the antigen-based screening programme 
had Cq values > 30 at the moment of testing. While this 
may indicate a lower viral load and infectivity at this 
stage, Cq trajectories in positive cases over time are 
unclear, and some cases in the early phase of infection 
might have subsequently developed lower Cq values.
Our study has strengths and limitations. By combin-
ing nationwide data on the antigen-based screening 
programme with RT-qPCR testing in a carefully chosen 
representative sample of schools, we provide a unique 
insight into the potential and limitations of one of the 
key measures to mitigate SARS-CoV-2 transmission in 
Figure 3
Modelled sensitivity of antigen-based anterior nasal self-testing programme assuming a range of positive predictive values 
and point estimates of the negative predictive value detected in the School-SARS-CoV-2 study, Austria, March 2021 
Dark orange: point estimates; light orange areas: 95% confidence interval limits. The numbers next to the grey circles are exemplary 
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schools. However, our findings may not be generalis-
able to other countries and antigen tests. Also, for 
reasons of data protection, only aggregate data were 
available from the screening programme, precluding 
more detailed analyses. Furthermore, health authori-
ties could not provide data on how frequently a posi-
tive rapid antigen test was confirmed with RT-qPCR. 
To account for this limitation, our modelling involved a 
range of positive predictive values.
Conclusion
Our study indicates that only a subset of infected indi-
viduals are detected with the antigen-based screening 
programme at Austrian schools (low to moderate sen-
sitivity). Non-infected individuals were largely tested 
negative (very high specificity). Given the low-to-
moderate sensitivity of antigen-based anterior nasal 
self-testing particularly in children, additional meas-
ures such as face masks or ventilation are important 
to prevent secondary cases, especially in periods with 
high incidence. Furthermore, as a mitigation measure, 
switching SARS-CoV-2 screening in schools to RT-qPCR 
based approaches should be preferred, where logisti-
cally feasible.
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